Table 1 Proportion of spinal transduced MNs in cats injected with scAAV9-CMV-GFP by intracisternal route
Age at injection | Cat | Proportion of GFP-positive MNs | |
---|---|---|---|
Cervical enlargement | Lumbar enlargement | ||
2 days (newborn) | C1 | 51.4±3.3 | 100 |
C2 | 100 | 100 | |
C3 | 98.7±1.3 | 99.7±0.3 | |
50 days (young) | C4 | 100 | 100 |
C5 | 48.2±3.2 | 95.6±2.3 | |
C6 | 100 | 100 |